Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1766342
Reference Type
Journal Article
Title
HPTLC method for the analysis of melatonin in bulk and pharmaceutical formulations
Author(s)
Agarwal, SP; Gonsalves, HJ; Khar, RK
Year
2008
Is Peer Reviewed?
Yes
Journal
Asian Journal of Chemistry
ISSN:
0970-7077
EISSN:
0975-427X
Volume
20
Issue
4
Page Numbers
2531-2538
Web of Science Id
WOS:000259602400007
Abstract
A simple, precise and stability-indicating high performance thin-layer chromatographic method of analysis of melatonin both as bulk drug and in pharmaceutical formulation was developed and validated. The method employed TLC aluminium plates precoated with silica gel 60F-254 as the stationary phase and mobile phase comprising toluene:ethyl acetate:formic acid (5:4.5:0.5 v/v). Densitometric analysis of melatonin was carried out in the absorbance mode at 290 nm. The linear regression analysis data for the calibration plots showed good linear relationship with r = 0.9989, with respect to peak area, in the concentration range 100-600 ng/ spot. The method was validated for precision, specificity, recovery and robustness.. The recovery of the drug from tablets carried out by standard addition method was found to be 99.72 +/- 0.682. Statistical analysis proves that the method is repeatable, selective and accurate for the estimation of the drug. Forced degradation studies showed the effect of variations in pH, UV light and high temperature on the stability of melatonin. As the proposed method could effectively separate the drug from its degradation products, it can be employed as a stability-indicating method.
Keywords
melatonin; HPTLC; stability indicating
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity